Best Coronary Revascularization Strategy in Diabetic Patients
[Speaker] 박덕우/울산의대
Secondary Prevention for Coronary Artery Disease in Diabetic Patients
[Speaker] 홍순준/고려의대
From Evidence to Practice: SGLT2 Inhibitors for CV Risk Reduction in Diabetes
[Speaker] 임수/서울의대
From Evidence to Practice: GLP-1 Analogues for CV Risk Reduction in Diabetes
[Speaker] 김병준/가천의대
Discussion